Expression of Epstein—Barr virus latent membrane protein influences self-renewal and differentiation in a multipotential murine haemopoietic ‘stem cell’ line

References

1. Anderson L. C., Jokinen M., Gahmberg C. G. 1978; Induction of erythroid differentiation in the human leukaemic cell line K562. Nature, London 278:364–365
   [Google Scholar]
2. Baichwal V. J., Sugden B. 1988; Transforation of Balb 3T3 cells by the BNLF-1 gene of Epstein—Barr virus. Oncogene 2:461–467
   [Google Scholar]
3. Baiceiwal V. J., Sugden B. 1989; The multiple membrane-spanning segments of the BNLF-1 oncogene for Epstein-Barr virus are required for transformation. Oncogene 4:67–74
   [Google Scholar]
4. Bornkamm G. W., Hindewentz J., Freese U. K., Zimber U. 1982; Deletion of the non-transforming EBV strain P3HR-1 causes fusion of the large internal repeat to the DSL region. Journal of Virology 43:952–968
   [Google Scholar]
5. Boulter C. A., Wagner E. 1987; A universal retroviral vector for efficient expression of exogenous genes. Nucleic Acids Research 15:7194
   [Google Scholar]
6. Brown A., Scott M. 1987; Retroviral vectors. In DNA Cloning vol. Ill, A Practical Approach pp 189–212 Edited by Glover D. M. Oxford: IRL Press;
   [Google Scholar]
7. Church G. M., Gilbert W. 1984; Genomic sequencing. Proceedings of the National Academy of Sciences, U.S.A 811991–1995
   [Google Scholar]
8. Collins S. J., Ruscetti F. W., Gallagher R. E., Gallo R. C. 1978; Terminal differentiation of human promyelocytic leukaemic cells induced by dimethylsulfoxide and other polar compounds. Proceedings of the National Academy of Sciences, U.S.A 752458–2462
   [Google Scholar]
9. Cordell J. L., Falini B., Erber W. N., Ghosh A. K., Abdulazy Z-, Macdonald S., Pulford S., Stejn K. A. F., Mason D. Y. 1984; Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and anti-alkaline phosphatase (APAAP complexes). Journal of Histology and Cytology 32:219–229
   [Google Scholar]
10. Cordier M., Calander A., Billaud M., Zimber U., Rousselet G., Pavlish O., Banchereau J., Tursz T., Bornkamm G., Lenoir G. M. 1990; Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR-1 genome induces expression of B-cell activation molecules CD21 and CD23. Journal of Virology 64:1002–1013
    [Google Scholar]
11. Cross M., Mangelsdorf I., Wengle A., Renkawitz R. 1988; Mouse lysozyme M gene: isolation, characterisation and expression. Proceedings of the National Academy of Sciences, U.S.A 856232–6236
    [Google Scholar]
12. Dambaugh T., Hennessy K., Fennewald S., Kieff E. 1986; The virus genome and its expression in latent infection. In The Epstein-Barr Virus: Recent Advances pp 13–45 Edited by Epstein M. A., Achong B. G. London: Heinemann;
    [Google Scholar]
13. Dawson C. W., Rickinson A. B., Young L. S. 1990; Epstein-Barr virus latent membrane proteins inhibit human epithelial cell differentiation. Nature, London 344:777–781
    [Google Scholar]
14. Dillner J., Kallin B. 1985; The Epstein-Barr virus proteins. Advances in Cancer Research 50:95–158
    [Google Scholar]
15. Epstein M., Achong B. 1986 In The Epstein-Barr Virus: Recent Advances pp 1–11 Edited by Epstein M. A., Achong B. G. London: Heinemann;
    [Google Scholar]
16. Fahrabus R., Fu H. L., Ernberg I., Fink J., Rowe M., Klein G., Falk K., Nilsson E., Yadau M., Busson P., Tursz T., Kallin B. 1988; Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. International Journal of Cancer 42:329–338
    [Google Scholar]
17. Fahraeus R., Rymo L., Rhim J. S., Klein G. 1990; Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature, London 345:447–449
    [Google Scholar]
18. Fennewald S., Van Santin V., Kieff E. 1984; Nucleotide sequence of an RNA transcribed in latent growth transforming virus infection indicates that it may encode a membrane protein. Journal of Virology 51:411–419
    [Google Scholar]
19. Glisin V., Crkvenjakov R., Byus C. 1974; Ribonucleic acid isolated by caesium chloride centrifugation. Biochemistry 13:2633–2636
    [Google Scholar]
20. Gordon J., Walker L., Guy G., Brown G., Rowe M., Rickinson A. B. 1986; Control of B lymphocyte replication. II. Transforming Epstein-Barr virus exploits three distinct viral signals to undermine three separate control points in B-cell growth. Immunology 58:591–595
    [Google Scholar]
21. Hammerschmidt W., Sugden B. 1989; Genetic analysis of immortalising function of Epstein-Barr virus in human B-lymphocytes. Nature, London 340:393–397
    [Google Scholar]
22. Hammerschmidt W., Sugden B., Baichwal V. R. 1989; The transforming domain alone of the latent membrane protein of Epstein—Barr virus is toxic to cells when expressed at high levels. Journal of Virology 63:2469–2475
    [Google Scholar]
23. Hennessy K., Fennewald S., Hummel M., Cole T., Kieff E. 1984; A membrane protein encoded by Epstein-Barr virus in latent growth transforming infection. Proceedings of the National Academy of Sciences U.S.A 81:7207–7211
    [Google Scholar]
24. Heyworth C. M., Dextter T. M., Kan O., Whetton A. D. 1990; The role of haemopoietic growth factors in self renewal and differentiation of IL-3 dependent multipotential stem cells. Growth Factors 2:197–211
    [Google Scholar]
25. Karasuyama H., Melchers F. 1988; Establishment of mouse cell lines which constitutively secrete large quantities of interleukins 2, 3, 4 or 5 using modified cDNA expression vectors. European Journal of Immunology 18:97–104
    [Google Scholar]
26. King W., Dambaugh T., Heller M., Dowling J., Kieff E. 1982; Epstein-Barr virus DNA XII. A variable region of the Epstein-Barr virus genome is included in the P3HR-1 deletion. Journal of Virology 43:979–986
    [Google Scholar]
27. Laux G., Perricaudet M., Farrell P. J. 1988; A spliced Epstein—Barr virus gene expressed in immortalised lymphocytes is created by circularisation of the linear genome. EMBO Journal 7:769–774
    [Google Scholar]
28. Miller G., Robinson J., Heston L., Lipman M. 1974; Differences between laboratory strains of Epstein-Barr virus based on imabortive infection and interference. Proceedings of the National Academy of Sciences, U.S.A 714006–4010
    [Google Scholar]
29. Revoltella R. P., Vignetti E., Fruscalzo A., Park M., Ragona G., Roccm G., Calef E. 1989; Epstein-Barr virus DNA sequences in precursor monocyte-macrophage cell lines established from the bone marrow of children with maturation defects of haematopoiesis. Journal of General Virology 70:1203–1215
    [Google Scholar]
30. Rowe D. T., Hall L., Joab I., Laux G. 1990; Identification of the Epstein—Barr virus terminal protein gene product in latently infected lymphocytes. Journal of Virology 64:2866–2875
    [Google Scholar]
31. Rowe M., Evans H. S., Young L. S., Hennessy K., Kieff E., Rickinson A. B. 1987; Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells. Journal of General Virology 68:1575–1586
    [Google Scholar]
32. Spooncer E., Heyworth C. M., Dunn A., Dexter T. M. 1986; Self-renewal and differentiation of interleukin-3-dependent multipotential stem cells are modulated by stromal ceUs and serum factors. Differentiation 31:111–118
    [Google Scholar]
33. Stewart J. P., Hampson I. N., Heinrich H.-W., Mackett M., Arrand J. R. 1989; Enhanced expression of the Epstein-Barr virus latent membrane protein by a recombinant vaccinia virus. Journal of General Virology 70:1231–1237
    [Google Scholar]
34. Wang D., Leibowitz D., Kieff E. 1985; An EBV membrane protein expressed in immortalised lymphocytes transforms established rodent cell. Cell 43:831–840
    [Google Scholar]
35. Wang D., Leibowitz D., Kieff E. 1988a; The truncated form of the Epstein-Barr virus latent infection membrane protein expressed in replication does not transform rodent fibroblasts. Journal of Virology 62:2337–2346
    [Google Scholar]
36. Wang D., Leibowitz D., Wang F., Gregory C., Rickinson A., Larson R., Springer T., Kieff E. 1988b; Hpsteia-Barr virus latent membrane protein alters the phenotype of the human B-lymphocyte: deletion of the amino terminus abolishes activity. Journal of Virology 62:4173–4184
    [Google Scholar]
37. Wang F., Gregory C. D., Rowe M., Rickinson A. B., Wang D., Birkenbach M., Kikutani H., Kishimoto T., Kieff E. 1987; Epstein—Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Proceedings ofthe National Academy of Sciences, U.S.A 843452–3456
    [Google Scholar]
38. Wang F., Gregory C., Sample C., Rowe M., Leibowitz D., Murray R., Rickinson A., Kieff E. 1990; Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B-lymphocytes: EBNA2 and LMP1 cooperatively induce CD23. Journal of Virology 64:2309–2318
    [Google Scholar]
39. Young L. S., Dawson C. W., Clarke D., Rupani H., Busson P. B., Tursz T., Johnson A., Rickinson A. B. 1988; Epstein-Barr virus gene expression in nasopharyngeal carcinoma. Journal of General Virology 69:1051–1065
    [Google Scholar]